Medtronic Chases Edwards Leadership In Transcatheter Heart Valves

Medtronic and Edwards Lifesciences transcatheter heart valves are fast-becoming common devices in the medical field, with promises of attracting healthier patients as well as ill ones. Medtronic moved into the field in a major way when it paid $1 billion to buy a pair of small firms developing the technology. Medtronic’s move was intended in part to enable it to compete with Edwards’ leadership in the field. (Click here for more)

“The Ever-Evolving Heart Valve” – St. Paul Pioneer Press (11/20/09)

JUST PUBLISHED: Medical Device Market 2009: Interventional Cardiology - Find out who’s going beyond catheters and drug-eluting stents in this vibrant space with this 86-page Special Report previously published in IN VIVO: The Business & Medicine Report. Order yours now!